Cirrhosis/Liver Failure

Top Story

Dicerna readies alpha-1 antitrypsin deficiency-related liver disease drug for trial

July 2, 2019

FDA grants fast track to alpha-1 antitrypsin deficiency-related liver disease drug

June 28, 2019
The FDA granted fast track designation to ARO-AAT, Arrowhead Pharmaceuticals’ second generation subcutaneously administered RNA interference therapeutic, for the…

Cirrhosis update: 5 reports on improving patient care

June 21, 2019
Cirrhosis, or late stage fibrosis, can result from a variety of causes including progression from nonalcoholic fatty liver disease and very often from alcohol-related…
In the Journals

Patients with severe psoriasis at risk for advanced liver fibrosis

June 11, 2019
Patients with central obesity, insulin resistance and active psoriasis are at high risk for liver fibrosis, according to researchers from King’s College London…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News Coverage

MAIT cells found to be dysfunctional in patients with alcoholic liver disease

April 29, 2015
More »